Results 61 to 70 of about 373,665 (256)

Mortality in septic patients treated with vitamin C: a systematic meta-analysis

Critical Care, 2021
Background Supplementation of vitamin C in septic patients remains controversial despite eight large clinical trials published only in 2020. We aimed to evaluate the evidence on potential effects of vitamin C treatment on mortality in adult septic ...
Sean S. Scholz, Rainer Borgstedt, Nicole Ebeling, Leoni C. Menzel, Gerrit Jansen, Sebastian Rehberg   +5 more
doaj   +1 more source

European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism

BJS (British Journal of Surgery), EarlyView., 2020
Some 5861 patients undergoing first‐time surgery for sporadic primary hyperparathyroidism were registered in the Eurocrine® database between 2015 and 2018. The use of intraoperative parathyroid hormone measurement decreased the risk of conversion and persistent hypercalcaemia.
A. Bergenfelz, S. van Slycke, Ö. Makay, L. Brunaud   +3 more
wiley   +1 more source

Adjunctive intravenous then oral vitamin C for moderate and severe community-acquired pneumonia in hospitalized adults: feasibility of randomized controlled trial

Scientific Reports, 2023
Patients hospitalised with community acquired pneumonia (CAP) have low peripheral blood vitamin C concentrations and limited antioxidant capacity.
Stephen T. Chambers, Malina Storer, Amy Scott-Thomas, Sandy Slow, Jonathan Williman, Michael Epton, David R. Murdoch, Sarah Metcalf, Anitra Carr, Heather Isenman, Michael Maze   +10 more
doaj   +1 more source

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases

BJS (British Journal of Surgery), EarlyView., 2020
This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek, M. Almquist, A. O. Bergenfelz, T. J. Musholt, E. Nordenström, on behalf of the EUROCRINE® Council, M. Almquist, M. Barczynski, L. Brunaud, T. Clerici, M. H. Hansen, M. Iacobone, Ö. Makay, F. F. Palazzo, N. Muñoz‐Pérez, M. Raffaelli, P. Riss, S. van Slycke, M. R. Vriens   +18 more
wiley   +1 more source

Vitamin C supplementation in the critically ill: A systematic review and meta-analysis

SAGE Open Medicine, 2018
Background: Low plasma levels of vitamin C are associated with adverse outcomes, including increased mortality, in critically ill patients. Several trials have suggested that the administration of intravenous vitamin C in this setting may have beneficial
Michael Zhang, David F Jativa
doaj   +1 more source

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia

Antioxidants, 2018
A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014).
Mike N. Foster, Anitra C. Carr, Alina Antony, Selene Peng, Mike G. Fitzpatrick   +4 more
doaj   +1 more source

INTRAVENOUS VITAMIN C SUPPLEMENTATION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: SALUTARY IMPACT ON CLINICAL OUTCOMES

medRxiv, 2023
Intravenous (IV) vitamin C improves organ function and reduces inflammation in sepsis, an inflammatory state like the post-hematopoietic stem cell transplant (SCT) milieu.
Gary Simmons, Roy Sabo, M. Aziz, Erika J. Martin, R. Bernard, M. Sriparna, Cody McIntire, E. Krieger, Donald F Brophy, Ramesh Natarajan, Alpha Fowler, C. Roberts, Amir Toor   +12 more
semanticscholar   +1 more source

Effect of high-dose intravenous vitamin C on inflammation in cancer patients [PDF]

Journal of Translational Medicine, 2012
An inflammatory component is present in the microenvironment of most neoplastic tissues. Inflammation and elevated C-reactive protein (CRP) are associated with poor prognosis and decreased survival in many types of cancer.Vitamin C has been suggested as having both a preventative and therapeutic role in a number of pathologies when administered at much
Mikirova Nina, Casciari Joseph, Rogers Andrea, Taylor Paul   +3 more
openaire   +3 more sources

Vitamin C in Cancer: A Metabolomics Perspective

Frontiers in Physiology, 2018
There is an ongoing interest in cellular antioxidants and oxidants as well as cellular mechanisms underlying their effects. Several reports suggest that vitamin C (L-ascorbic acid) functions as a pro-oxidant with selective toxicity against specific types
Seyeon Park, Seunghyun Ahn, Yujeong Shin, Yoonjung Yang, Chang H. Yeom   +4 more
doaj   +1 more source

Review of high‐dose intravenous vitaminCas an anticancer agent [PDF]

Asia-Pacific Journal of Clinical Oncology, 2014
AbstractIn the 1970s,Pauling andCameron reported increased survival of patients with advanced cancer treated with high‐dose intravenous (IV) vitaminC(L‐ascorbate, ascorbic acid). These studies were criticized for their retrospective nature and lack of standardization of key prognostic factors including performance status.
Michelle K, Wilson, Bruce C, Baguley, Clare, Wall, Michael B, Jameson, Michael P, Findlay   +4 more
openaire   +2 more sources